Related Experiment Video
Updated: Jul 7, 2026
09:28
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results
Marion B Coulter-Mackie1, Qun Lian, Derek A Applegarth
1Department of Pediatrics, University of British Columbia, Vancouver, Canada. marioncm@interchange.ubc.ca
Clinical Biochemistry
|February 20, 2008
Summary
Testing for specific mutations in the alanine:glyoxylate aminotransferase (AGT) gene aids in diagnosing primary hyperoxaluria type 1 (PH1). A focused mutation panel identified causative mutations in 64% of PH1 patient samples.
Area of Science:
- Biochemistry
- Genetics
- Medical Diagnostics
Background:
- Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder.
- Accurate diagnosis of PH1 is crucial for effective management.
- The alanine:glyoxylate aminotransferase (AGT) gene plays a key role in PH1 pathogenesis.
Purpose of the Study:
- To develop and evaluate a targeted mutation testing panel for the AGT gene.
- To improve the diagnostic accuracy of primary hyperoxaluria type 1 (PH1).
Main Methods:
- Analysis of liver and DNA samples from 81 patients undergoing PH1 diagnostic testing.
- Utilized a panel of selected AGT gene mutations for DNA examination in 64 cases.
- Employed DNA sequencing for cases with single identified mutations.
Main Results:
- A focused testing panel was developed, encompassing 4 common mutations, 7 less frequent mutations, and 5 with ethnic associations.
- This panel successfully identified 100% of mutations in AGT-confirmed PH1 samples.
- The developed mutation panel could have identified both causative mutations in 64% of the PH1 patient samples.
Conclusions:
- A targeted mutation panel for the AGT gene is effective for diagnosing PH1.
- The developed panel significantly aids in identifying causative mutations for PH1.
- This diagnostic approach enhances the ability to detect and manage PH1.
